{
    "price_data": [
        [
            1679941800000,
            178
        ],
        [
            1680028200000,
            177
        ],
        [
            1680201000000,
            179
        ],
        [
            1680460200000,
            179
        ],
        [
            1680633000000,
            181
        ],
        [
            1680719400000,
            183
        ],
        [
            1681065000000,
            182
        ],
        [
            1681151400000,
            183
        ],
        [
            1681237800000,
            190
        ],
        [
            1681324200000,
            187
        ],
        [
            1681669800000,
            187
        ],
        [
            1681756200000,
            194
        ],
        [
            1681842600000,
            194
        ],
        [
            1681929000000,
            194
        ],
        [
            1682015400000,
            194
        ],
        [
            1682274600000,
            196
        ],
        [
            1682361000000,
            196
        ],
        [
            1682447400000,
            198
        ],
        [
            1682533800000,
            194
        ],
        [
            1682620200000,
            194
        ]
    ],
    "price_data_2": [
        {
            "time": "2023-03-28",
            "value": 178
        },
        {
            "time": "2023-03-29",
            "value": 177
        },
        {
            "time": "2023-03-31",
            "value": 179
        },
        {
            "time": "2023-04-03",
            "value": 179
        },
        {
            "time": "2023-04-05",
            "value": 181
        },
        {
            "time": "2023-04-06",
            "value": 183
        },
        {
            "time": "2023-04-10",
            "value": 182
        },
        {
            "time": "2023-04-11",
            "value": 183
        },
        {
            "time": "2023-04-12",
            "value": 190
        },
        {
            "time": "2023-04-13",
            "value": 187
        },
        {
            "time": "2023-04-17",
            "value": 187
        },
        {
            "time": "2023-04-18",
            "value": 194
        },
        {
            "time": "2023-04-19",
            "value": 194
        },
        {
            "time": "2023-04-20",
            "value": 194
        },
        {
            "time": "2023-04-21",
            "value": 194
        },
        {
            "time": "2023-04-24",
            "value": 196
        },
        {
            "time": "2023-04-25",
            "value": 196
        },
        {
            "time": "2023-04-26",
            "value": 198
        },
        {
            "time": "2023-04-27",
            "value": 194
        },
        {
            "time": "2023-04-28",
            "value": 194
        }
    ],
    "more_info": {
        "address1": "17-B, Mahal Industrial Estate",
        "address2": "Off Mahakali Caves Road Andheri (East)",
        "city": "Mumbai",
        "zip": "400093",
        "country": "India",
        "phone": "91 22 6645 5645",
        "fax": "91 22 6645 5685",
        "website": "https://www.sparc.life",
        "industry": "Drug Manufacturers\u2014Specialty & Generic",
        "sector": "Healthcare",
        "longBusinessSummary": "Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops new chemical and biological entities, and reformulated products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, dermatology, and Immunology. The company offers Elepsia, a formulation of levetiracetam that is an anti-epileptic agent to treat epilepsy disorder; and Xelpros, a latanoprost ophthalmic emulsion for the treatment of open-angle glaucoma or ocular hypertension. In addition, it is developing SDN-037, a formulation of difluprednate for the treatment of inflammation and pain associated with ocular surgery that is in phase 3 clinical trial; PDP-716 to treat glaucoma, which is in phase 3 clinical trial; phenobarbital sodium for the treatment of neonatal seizures; Vodobatinib (SCO-088) for the treatment of resistant chronic myelogenous leukemia that has completed a part A of the Phase 1 study; Vodobatinib (SCC-138), which is in phase 2 clinical trial to treat Parkinson's disease; SCD-044 for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial; and SCO-120 for the treatment of hormone receptor-positive, human epidermal receptor 2 negative, and metastatic breast cancer, which is in phase 1 clinical trial. Sun Pharma Advanced Research Company Limited has a collaboration agreement with Bioprojet to develop an S1P receptor 1 agonist for autoimmune disorders. The company was incorporated in 2006 and is based in Mumbai, India. Sun Pharma Advanced Research Company Limited is a subsidiary of Shanghvi Finance Private Limited.",
        "fullTimeEmployees": 403,
        "companyOfficers": [
            {
                "maxAge": 1,
                "name": "Mr. Anilkumar  Raghavan",
                "age": 53,
                "title": "Chief Exec. Officer",
                "yearBorn": 1969,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Chetan M. Rajpara",
                "title": "Chief Financial Officer",
                "fiscalYear": 2020,
                "totalPay": 15143000,
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Siu-Long  Yao",
                "title": "Exec. VP Clinical Devel. & Operations",
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Jaydeep  Issrani",
                "title": "Sr. Gen. Mang. of Bus. Devel., Corp. Communication & Investor Relations",
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Dinesh Poosraj Lahoti",
                "title": "Company Sec. & Compliance Officer",
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Rajesh  Ranganathan",
                "title": "Vice-Pres Corp. Devel.",
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Ms. Shanta  Gupta",
                "title": "Chief Human Resource Officer",
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Nitin K. Damle Ph.D.",
                "title": "Sr. VP & Chief Innovation Officer",
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Mr. Vikram  Ramanathan",
                "title": "VP & Head of Translational Devel.",
                "exercisedValue": 0,
                "unexercisedValue": 0
            },
            {
                "maxAge": 1,
                "name": "Dr. Venkata  Palle",
                "title": "Exec. VP & Global Head of Drug Discovery and Preclinical Devel.",
                "exercisedValue": 0,
                "unexercisedValue": 0
            }
        ],
        "compensationAsOfEpochDate": 1609372800,
        "maxAge": 86400,
        "priceHint": 2,
        "previousClose": 194.5,
        "open": 195.5,
        "dayLow": 192.7,
        "dayHigh": 197.9,
        "regularMarketPreviousClose": 194.5,
        "regularMarketOpen": 195.5,
        "regularMarketDayLow": 192.7,
        "regularMarketDayHigh": 197.9,
        "payoutRatio": 0.0,
        "beta": 0.710023,
        "forwardPE": 4.457275,
        "volume": 479395,
        "regularMarketVolume": 479395,
        "averageVolume": 1267608,
        "averageVolume10days": 762137,
        "averageDailyVolume10Day": 762137,
        "bid": 0.0,
        "ask": 194.7,
        "bidSize": 0,
        "askSize": 0,
        "marketCap": 62632742912,
        "fiftyTwoWeekLow": 162.1,
        "fiftyTwoWeekHigh": 267.0,
        "priceToSalesTrailing12Months": 28.952553,
        "fiftyDayAverage": 184.985,
        "twoHundredDayAverage": 214.19725,
        "trailingAnnualDividendRate": 0.0,
        "trailingAnnualDividendYield": 0.0,
        "currency": "INR",
        "enterpriseValue": 55295844352,
        "profitMargins": -0.97830003,
        "floatShares": 78774973,
        "sharesOutstanding": 324521984,
        "heldPercentInsiders": 0.64896005,
        "heldPercentInstitutions": 0.014049999,
        "impliedSharesOutstanding": 0,
        "bookValue": -4.372,
        "lastFiscalYearEnd": 1648684800,
        "nextFiscalYearEnd": 1680220800,
        "mostRecentQuarter": 1672444800,
        "netIncomeToCommon": -2116354048,
        "trailingEps": -7.67,
        "forwardEps": 43.3,
        "enterpriseToRevenue": 25.561,
        "enterpriseToEbitda": -28.535,
        "52WeekChange": -0.2537371,
        "SandP52WeekChange": 0.0033931732,
        "exchange": "NSI",
        "quoteType": "EQUITY",
        "symbol": "SPARC.NS",
        "underlyingSymbol": "SPARC.NS",
        "shortName": "SUN PHARMA ADV",
        "longName": "Sun Pharma Advanced Research Company Limited",
        "firstTradeDateEpochUtc": 1042515900,
        "timeZoneFullName": "Asia/Kolkata",
        "timeZoneShortName": "IST",
        "uuid": "9062bc49-09d4-3cc0-972e-5819d39e5a1a",
        "messageBoardId": "finmb_29870145",
        "gmtOffSetMilliseconds": 19800000,
        "currentPrice": 193.0,
        "targetHighPrice": 1185.0,
        "targetLowPrice": 1185.0,
        "targetMeanPrice": 1185.0,
        "targetMedianPrice": 1185.0,
        "recommendationKey": "none",
        "numberOfAnalystOpinions": 1,
        "totalCash": 41900000,
        "totalCashPerShare": 0.153,
        "ebitda": -1937792000,
        "totalDebt": 1926800000,
        "totalRevenue": 2163289088,
        "revenuePerShare": 7.985,
        "grossProfits": 1102606000,
        "revenueGrowth": 1.109,
        "grossMargins": 0.85472,
        "ebitdaMargins": -0.89575994,
        "operatingMargins": -0.93160003,
        "financialCurrency": "INR",
        "trailingPegRatio": null
    }
}